We are live on
!
Find out more
Primecap Management Portfolio holdings
AUM
$127B
1-Year Est. Return
44.11%
This Fund
S&P 500
This Quarter
Est. Return
+3.92%
1 Year Est. Return
+44.11%
3 Year Est. Return
+121.64%
5 Year Est. Return
+154.22%
10 Year Est. Return
+724.54%
AUM
$133B
AUM Growth
+$2.97B
(+2.3%)
Cap. Flow
+$494M
Cap. Flow
% of AUM
0.37%
Top 10 Holdings %
Top 10 Hldgs %
28.35%
Holding
293
New
7
Increased
75
Reduced
134
Closed
7
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$635M |
| 2 |
United Airlines
UAL
|
+$620M |
| 3 |
Qualcomm
QCOM
|
+$401M |
| 4 |
BioMarin Pharmaceuticals
BMRN
|
+$302M |
| 5 |
Whirlpool
WHR
|
+$249M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$442M |
| 2 |
BIVV
Bioverativ Inc. Common Stock
BIVV
|
+$411M |
| 3 |
Adobe
ADBE
|
+$359M |
| 4 |
Texas Instruments
TXN
|
+$345M |
| 5 |
AT&T
T
|
+$284M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.69% |
| 2 | Healthcare | 23.27% |
| 3 | Industrials | 16.23% |
| 4 | Consumer Discretionary | 9.05% |
| 5 | Financials | 8.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ONC
126
BeOne Medicines Ltd
ONC
$39.4B
| $144M | 0.11% |
857,499
+550,479
| +179% | +$74.6M |
|
|
EA
127
DELISTED
Electronic Arts
EA
| $144M | 0.11% |
1,184,225
-70,750
| -6% | -$8.58M |
|
128
Apple
AAPL
$4.57T
| $143M | 0.11% |
3,420,400
-265,600
| -7% | -$11.4M |
|
129
Transocean
RIG
$5.82B
| $139M | 0.1% |
14,055,895
-166,562
| -1% | -$1.71M |
|
130
Descartes Systems
DSGX
$6.82B
| $127M | 0.1% |
4,440,590
-100,800
| -2% | -$2.81M |
|
131
Rockwell Automation
ROK
$49B
| $127M | 0.1% |
727,515
-2,420
| -0.3% | -$459K |
|
132
MGM Resorts International
MGM
$11.2B
| $124M | 0.09% |
3,527,600
| – | – |
|
133
IMAX
IMAX
$2.66B
| $121M | 0.09% |
6,287,900
| – | – |
|
|
SPPI
134
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $119M | 0.09% |
7,420,000
+2,854,000
| +63% | +$56.5M |
|
135
Zimmer Biomet
ZBH
$18.4B
| $119M | 0.09% |
1,126,860
+232,717
| +26% | +$27M |
|
136
Johnson & Johnson
JNJ
$625B
| $117M | 0.09% |
909,475
-11,848
| -1% | -$1.6M |
|
137
Marriott International
MAR
$92.3B
| $105M | 0.08% |
773,346
-3,054
| -0.4% | -$428K |
|
138
Jabil
JBL
$35.8B
| $104M | 0.08% |
3,627,337
-43,113
| -1% | -$1.17M |
|
|
FARO
139
DELISTED
Faro Technologies
FARO
| $104M | 0.08% |
1,775,000
-5,500
| -0.3% | -$305K |
|
140
IDEX
IEX
$17.3B
| $102M | 0.08% |
715,780
-58,250
| -8% | -$8.13M |
|
141
Newell Brands
NWL
$2.56B
| $102M | 0.08% |
4,002,060
-39,200
| -1% | -$1.11M |
|
142
Pentair
PNR
$11B
| $100M | 0.08% |
2,185,703
-6,850
| -0.3% | -$326K |
|
143
Comcast
CMCSA
$90B
| $98.3M | 0.07% |
2,878,000
| – | – |
|
|
PARA
144
DELISTED
Paramount Global Class B
PARA
| $91.4M | 0.07% |
1,779,057
+55,000
| +3% | +$3.02M |
|
145
Salesforce
CRM
$158B
| $84.8M | 0.06% |
729,360
+50,000
| +7% | +$5.74M |
|
146
Teradyne
TER
$59.3B
| $84.6M | 0.06% |
1,851,264
+60,950
| +3% | +$2.79M |
|
|
IRBT
147
DELISTED
iRobot
IRBT
| $80.8M | 0.06% |
1,258,000
+575,000
| +84% | +$43.3M |
|
148
Sanofi
SNY
$104B
| $78.4M | 0.06% |
1,956,000
| – | – |
|
149
Edwards Lifesciences
EW
$51.7B
| $74.6M | 0.06% |
1,605,000
+105,000
| +7% | +$4.56M |
|
150
RTX Corp
RTX
$301B
| $73.9M | 0.06% |
933,379
-238,032
| -20% | -$19.7M |
|
Similar funds
VAM
Primecap Management's Q1 2018 Portfolio in Review
As of Q1 2018, Primecap Management held 293 positions worth $133B, up 2.3% from $130B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Trading was light in Q1 2018: portfolio turnover was 4.8%. Primecap Management opened 7 new positions and exited 7, leaving the 293-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 31% a quarter earlier, followed by Healthcare and Industrials.
- Primecap Management's largest Q1 2018 buy was Moody's: 181,000 shares worth $29.2M.
- Primecap Management added most to Bristol-Myers Squibb in Q1 2018, an estimated $635M increase.
- Primecap Management's biggest Q1 2018 reduction was NVIDIA, cutting an estimated $442M.
- Primecap Management fully exited Bioverativ Inc. Common Stock in Q1 2018, selling an estimated $411M.
- Primecap Management's ten largest holdings make up 28% of its $133B portfolio in Q1 2018.
- Primecap Management opened 7 new positions and closed 7 in Q1 2018.
- Primecap Management's portfolio value rose 2.3% quarter-over-quarter to $133B.
Based on Primecap Management's 13F filing for Q1 2018, filed 14 May 2018.